Manufacture of basic pharmaceutical products and pharmaceutical preparations (PKD division 21)
This division includes:
- the production of basic pharmaceutical substances,
- the production of medicines, including homeopathic preparations,
- the production of other pharmaceutical products.
Industry statistics (2025)
Number of companies
Companies
Business turnover
Legal structure
Legal formShare of companiesNumber of companies
- Sp. z o.o.76.4%469
- Sp. j.8.1%50
- S.A.6.7%41
- JDG2.4%15
- Sp. k.2.3%14
- P.S.A.1.6%10
- Cooperative1.0%6
- Other0.8%5
- Foundation0.5%3
Financial results
Median revenue
Ranking
Median revenue compared with other PKD codes.
Top companies by revenue
| # | Company | Legal form | Revenue | Net profit |
|---|---|---|---|---|
| 1 | S.A. | USD 1.36bn | USD 276.81m | |
| 2 | S.A. | USD 615.32m | USD 16.99m | |
| 3 | S.A. | USD 539.49m | USD 53.86m | |
| 4 | sp. z o.o. | USD 527.04m | USD 77.39m | |
| 5 | sp. z o.o. | USD 300.66m | USD 59.18m | |
| 6 | sp. z o.o. | USD 245.99m | USD 33.23m | |
| 7 | S.A. | USD 159.45m | USD 6.68m | |
| 8 | sp. z o.o. | USD 142.78m | USD 34.11m | |
| 9 | S.A. | USD 119.08m | USD 4.98m | |
| 10 | sp. z o.o. | USD 112.36m | USD 2.95m |
Fastest-growing companies
| # | Company | Legal form | Revenue | Y/Y growth |
|---|---|---|---|---|
| 1 | sp. z o.o. | USD 101.19m | +333.1% y/y | |
| 2 | sp. z o.o. | USD 47.06m | +92.4% y/y | |
| 3 | sp. z o.o. | USD 3.81m | +83.9% y/y | |
| 4 | sp. z o.o. | USD 7.35m | +80.7% y/y | |
| 5 | sp. z o.o. | USD 1.81m | +66.3% y/y | |
| 6 | sp. z o.o. | USD 1.35m | +58.6% y/y | |
| 7 | sp. z o.o. | USD 21.37m | +57.8% y/y | |
| 8 | sp. z o.o. | USD 4.24m | +54.9% y/y | |
| 9 | sp. z o.o. | USD 1.97m | +50.5% y/y | |
| 10 | sp. z o.o. | USD 2.14m | +49.3% y/y |
Stock market
6 companies from this industry are listed.
| Company | Ticker | Market | Price | Change | Market cap |
|---|---|---|---|---|---|
| CLN | GPW Main Market | PLN 15.56 | -1.52% | USD 209.72m | |
| BIO | GPW Main Market | PLN 3.46 | +0.73% | USD 74.27m | |
| SVE | GPW Main Market | PLN 2.84 | -0.18% | USD 53.88m | |
| PTG | GPW Main Market | PLN 18.90 | -0.53% | USD 27.96m | |
| SCS | NewConnect | PLN 0.51 | 0.00% | USD 5.27m | |
| MUN | NewConnect | PLN 0.28 | -2.43% | USD 3.30m |
PKD codes in division 21
FAQ
The primary industry for 614 companies is manufacture of basic pharmaceutical products and pharmaceutical preparations. 330 entities have filed financial statements.
So far in 2026, 12 new companies with PKD 21 have been registered. In all of 2025, there were 27 such companies.
So far in 2026, 2 companies with PKD 21 have been deregistered. In all of 2025, there was 1 such company.
In 2025, the median revenue for PKD 21 was USD 910.84k and the mean revenue was USD 27.19m, based on 243 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.
Yes, in 2025, the median net profit was USD 26.11k, an improvement on 2024 (USD 9.51k). Among all 628 PKD divisions in Poland, it ranks 255th, putting it in the top 41%.
The most common legal form for PKD 21 is sp. z o.o., used by 469 companies in this industry (76.4% of the total). In second place is sp. j. (50 companies, 8.1%), and in third place – S.A. (41 companies, 6.7%).



















